Page 21 of 40
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
9
7.84 (m, 2H), 7.39-7.56 (m, 5H), 6.96-7.03 (m, 1H), 4.09 (dm, J = 56.9 Hz, 2H), 1.74 (quint., J = 7.0 Hz, 2H), 1.52 (s, 9H), 1.46 (sextuplet, J =
7.4 Hz, 2H), 0.94 (t, J = 7.4 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3): = 153.1, 144.1 (d, JPCCC = 5.8 Hz), 133.6 (d, JPCCCC = 2.0 Hz), 132.4 (d,
JPCC = 12.1 Hz), 132.4, 131.7 (d, JPC = 138 Hz), 131.2 (d, JPCCC = 10.3 Hz, 2C), 128.6 (d, JPCC = 13.6 Hz, 2C), 121.7 (d, JPCC = 12.5 Hz), 119.6
(d, JPCCC = 9.1 Hz), 115.6 (d, JPC = 129 Hz), 80.3, 65.2 (d, JPOC = 6.0 Hz), 32.5 (d, JPOCC = 6.6 Hz), 28.3 (3C), 18.9, 13.6; HRMS (EI+) m/z calcd
for C21H28NO4P ([M]+) 389.1756, found 389.1757.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Butyl [p-((S)-4-benzyl-2-oxazolidinone)] phenylphosphinate 11:
General procedure was used with (S)-4-benzyl-2-oxazolidinone (177 mg, 1 mmol, 1 equiv) and butyl phenyl-H-phosphinate19 (198 mg, 1 mmol,
1 equiv). The crude obtained was purified by column chromatography (dichloromethane/acetone 90:10 to 50:50) to afford the product as a
colorless oil (93 mg, 25%). 31P NMR (162 MHz, CDCl3): = 30.9 (s); 1H NMR (400 MHz, CDCl3): = 7.59-7.83 (m, 4H), 7.21-7.53 (m, 5H),
6.64 (s, 1H), 4.29-4.39 (m, 1H), 3.92-4.12 (m, 4H), 2.78-2.98 (m, 2H), 1.68 (quint., J = 6.5 Hz, 2H), 1.39 (sextuplet, J = 7.0 Hz, 2H), 0.89 (t, J
= 7.0 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3): = 159.5, 140.5 (d, JPCCCC = 2.5 Hz), 133.0 (d, JPCCCC = 2.5 Hz), 132.3 (d, JPCCC = 10.4 Hz),
132.2 (d, JPCCC = 10.4 Hz, 2C), 131.6 (d, JPCCC = 10.1 Hz, 2C), 131.4 (d, JPC = 137 Hz), 130.5 (d, JPC = 139 Hz), 129.4 (d, JPCC = 13.4 Hz, 2C),
128.6 (d, JPCC = 13.1 Hz), 128.6 (d, JPCC = 13.1 Hz), 69.2 (0.5C), 69.2 (0.5C), 64.9 (d, JPOC = 6.1 Hz, 0.5C), 64.8 (d, JPOC = 6.0 Hz, 0.5C), 53.4,
41.2 (0.5C), 41.0 (0.5C), 32.5 (d, JPOCC = 6.6 Hz), 18.8, 13.6; HRMS (EI+) m/z calcd for C20H25NO4P ([M+H]+) 374.1516, found 374.1520.
Butyl (p-tolylacetate) phenylphosphinate (mixture of ortho and meta isomers) 13:
General procedure was used with p-tolylacetate (751 mg, 5 mmol, 5 equiv) and butyl phenyl-H-phosphinate19 (198 mg, 1 mmol, 1 equiv). The
crude obtained was purified by column chromatography (dichloromethane/acetone 100:0 to 90:10) to afford the product as a colorless oil (100
mg, 29%). 31P NMR (162 MHz, CDCl3): = 30.0 (s, 46%, methyl in meta position) and 27.5 (s, 54%, methyl in ortho position); 1H NMR (400
MHz, CDCl3): = 7.84-7.90 (m, 0.5H), 7.71-7.81 (m, 2H), 7.62-7.68 (m, 0.5H), 7.39-7.55 (m, 3H), 7.32-7.38 (m, 0.5H), 7.12-7.22 (m, 1H), 6.94-
7.01 (m, 0.5H), 3.89-4.12 (m, 2H), 2.39 (s, 1.5H), 2.36 (s, 1.5H), 2.28 (s, 1.5H), 2.07 (s, 1.5H), 1.71 (quint., J = 6.8 Hz, 2H), 1.42 (sextuplet, J
= 7.4 Hz, 2H), 0.91 (t, J = 7.3 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3): = 169.3 (0.5C), 169.0 (0.5C), 153.1, 149.9 (d, JPCCC = 3.4 Hz, 0.5C),
148.3 (d, JPCC = 16.5 Hz, 0.5C), 139.3 (d, JPCCC = 10.9 Hz, 0.5C), 135.8 (d, JPCC = 11.4 Hz, 0.5C), 134.6 (d, JPCCC = 6.0 Hz, 0.5C), 134.4 (d,
JPCCCC = 2.1 Hz, 0.5C), 132.5 (d, JPCC = 14.3 Hz, 0.5C), 132.4 (d, JPC = 98.8 Hz, 0.5C), 132.1 (d, JPCCC = 5.3 Hz, 0.5C), 132.1 (d, JPCCC = 5.4
Hz, 0.5C), 131.6 (d, JPCCC = 10.5 Hz), 131.6 (d, JPC = 136 Hz, 0.5C), 131.1 (d, JPCCC = 10.7 Hz), 130.9 (d, JPC = 113 Hz, 0.5C), 128.5 (d, JPCC
13.3 Hz), 128.4 (d, JPCC = 13.8 Hz), 126.1 (d, JPCCC = 9.4 Hz, 0.5C), 125.5 (d, JPCCCC = 2.6 Hz), 123.4 (d, JPCCC = 8.1 Hz, 0.5C), 123.2 (d, JPC
=
=
133 Hz, 0.5C), 64.8 (d, JPOC = 5.9 Hz, 0.5C), 64.6 (d, JPOC = 5.9 Hz, 0.5C), 32.5 (d, JPOCC = 6.6 Hz), 21.0 (0.5H), 20.8 (0.5C), 20.8 (0.5C), 20.5
(d, JPCCC = 3.8 Hz, 0.5C), 18.9 (0.5C), 18.8 (0.5C), 13.6; HRMS (EI+) m/z calcd for C19H24O4P ([M+H]+) 347.1407, found 347.1402.
Butyl pyridyl phenylphosphinate (mixture of ortho and para derivatives) 14:
General procedure was used with pyridine (0.40 mL, 5 mmol, 5 equiv) and butyl phenyl-H-phosphinate19 (198 mg, 1 mmol, 1 equiv) to afford
the product as a colorless oil (93 mg, 34%). 31P NMR (162 MHz, CDCl3): = 28.0 (s, 38%) and 25.4 (s, 54%); 1H NMR (400 MHz, CDCl3): =
8.67-8.77 (m, 1H), 8.06-8.14 (m, 0.5H), 7.90-7.99 (m, 1H), 7.72-7.83 (m, 1.5H), 7.58-7.66 (m, 1H), 7.39-7.57 (m, 3H), 7.30-7.37 (m, 1H), 3.96-
4.09 (m, 2H), 1.63-1.74 (m, 2H), 1.33-1.46 (m, 2H), 0.89 and 0.86 (2t, J = 7.0 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3): = 154.8 (d, JPC
=
168 Hz, 0.6C), 150.5 (d, JPCC = 20.5 Hz, 0.4C), 150.1 (d, JPCC = 10.8 Hz, 0.4C), 150.0 (d, JPCCC = 3.2 Hz, 0.4C), 140.9 (d, JPC = 132 Hz, 0.4C),
136.0 (d, JPCC = 10.1 Hz, 0.6C), 132.8 (d, JPCCCC = 2.6 Hz, 0.4C), 132.3 (d, JPCCCC = 2.6 Hz, 0.6C), 132.3 (d, JPCCCC = 5.0 Hz, 0.6C), 132.2 (d,
ACS Paragon Plus Environment